BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 7120290)

  • 1. Synthesis and biological activity of 5'-substituted 5-fluoropyrimidine nucleosides.
    Ajmera S; Danenberg PV
    J Med Chem; 1982 Aug; 25(8):999-1002. PubMed ID: 7120290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and interaction with uridine phosphorylase of 5'-deoxy-4',5-difluorouridine, a new prodrug of 5-fluorouracil.
    Ajmera S; Bapat AR; Stephanian E; Danenberg PV
    J Med Chem; 1988 Jun; 31(6):1094-8. PubMed ID: 2967375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-Fluorouracil derivative. XVII. Synthesis and antitumor activity of 5'-O-acyl-5-fluorouridines.
    Ozaki S; Akiyama T; Ike Y; Mori H; Hoshi A
    Chem Pharm Bull (Tokyo); 1989 Dec; 37(12):3405-8. PubMed ID: 2632088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic antitumor effect of fluoropyrimidines and polyinosinic-polycytidylic acid against L1210 leukemia.
    Iigo M; Chapekar MS; Glazer RI
    Cancer Res; 1985 Sep; 45(9):4039-42. PubMed ID: 2411395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of 1-beta-D-arabinofuranosylcytosine metabolism and cytotoxicity in L1210 cells by fluoropyrimidine pretreatment.
    Grant S; Cadman E
    Cancer Res; 1982 Sep; 42(9):3550-6. PubMed ID: 6213294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differences in activities and substrate specificity of human and murine pyrimidine nucleoside phosphorylases: implications for chemotherapy with 5-fluoropyrimidines.
    el Kouni MH; el Kouni MM; Naguib FN
    Cancer Res; 1993 Aug; 53(16):3687-93. PubMed ID: 8339277
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Precursor-dependent differences in the incorporation of fluorouracil in RNA.
    Takimoto CH; Cadman EC; Armstrong RD
    Mol Pharmacol; 1986 Jun; 29(6):637-42. PubMed ID: 2940459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of uridine phosphorylase for antitumor activity of 5'-deoxy-5-fluorouridine.
    Ishitsuka H; Miwa M; Takemoto K; Fukuoka K; Itoga A; Maruyama HB
    Gan; 1980 Feb; 71(1):112-23. PubMed ID: 6445847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of guanosine on antitumor activity of fluorinated pyrimidines against P 388 leukemia.
    Iigo M; Hoshi A
    Cancer Chemother Pharmacol; 1984; 13(2):86-90. PubMed ID: 6235977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between ribosomal RNA production and RNA-directed fluoropyrimidine cytotoxicity.
    Takimoto CH; Tan YY; Cadman EC; Armstrong RD
    Biochem Pharmacol; 1987 Oct; 36(19):3243-8. PubMed ID: 2444230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2'-Fluorinated isonucleosides. 1. Synthesis and biological activity of some methyl 2'-deoxy-2'-fluoro-2'-pyrimidinyl-D-arabinopyranosides.
    Bobek M; An SH; Skrincosky D; De Clercq E; Bernacki RJ
    J Med Chem; 1989 Apr; 32(4):799-807. PubMed ID: 2704026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and anticancer activity of various 3'-deoxy pyrimidine nucleoside analogues and crystal structure of 1-(3-deoxy-beta-D-threo-pentofuranosyl)cytosine.
    Lin TS; Yang JH; Liu MC; Shen ZY; Cheng YC; Prusoff WH; Birnbaum GI; Giziewicz J; Ghazzouli I; Brankovan V
    J Med Chem; 1991 Feb; 34(2):693-701. PubMed ID: 1995894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective activation of 5'-deoxy-5-fluorouridine by tumor cells as a basis for an improved therapeutic index.
    Armstrong RD; Diasio RB
    Cancer Res; 1981 Dec; 41(12 Pt 1):4891-4. PubMed ID: 6171343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolism and biological activity of 5'-deoxy-5-fluorouridine, a novel fluoropyrimidine.
    Armstrong RD; Diasio RB
    Cancer Res; 1980 Sep; 40(9):3333-8. PubMed ID: 6253060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytostatic/cytotoxic effects of 5-fluorouridine nucleolipids on colon, hepatocellular, and renal carcinoma cells: in vitro identification of a potential cytotoxic multi-anticancer drug.
    Farhat A; Malecki E; Bonaterra GA; Röthlein D; Wolf M; Schmitt J; Rosemeyer H; Kinscherf R
    Chem Biodivers; 2014 Mar; 11(3):469-82. PubMed ID: 24634076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nucleosides and nucleotides. 97. Synthesis of new broad spectrum antineoplastic nucleosides, 2'-deoxy-2'-methylidenecytidine (DMDC) and its derivatives.
    Matsuda A; Takenuki K; Tanaka M; Sasaki T; Ueda T
    J Med Chem; 1991 Feb; 34(2):812-9. PubMed ID: 1995905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antitumor activity of two novel low immunosuppressive fluoropyrimidines UK-21 and UK-25.
    Sakamoto O; Mori H; Kitaichi K; Koda A; Kato T
    Jpn J Pharmacol; 1992 Aug; 59(4):469-76. PubMed ID: 1434142
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of uridine rescue to enhance the antitumor selectivity of 5-fluorouracil.
    Klubes P; Cerna I
    Cancer Res; 1983 Jul; 43(7):3182-6. PubMed ID: 6850628
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of the effects of fluoropyrimidines on toxicity and tumor inhibition in rodents by uridine and thymidine.
    Hartmann HR; Bollag W
    Med Oncol Tumor Pharmacother; 1986; 3(2):111-8. PubMed ID: 2943952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and anticancer and antiviral activities of various 2'- and 3'-methylidene-substituted nucleoside analogues and crystal structure of 2'-deoxy-2'-methylidenecytidine hydrochloride.
    Lin TS; Luo MZ; Liu MC; Clarke-Katzenburg RH; Cheng YC; Prusoff WH; Mancini WR; Birnbaum GI; Gabe EJ; Giziewicz J
    J Med Chem; 1991 Aug; 34(8):2607-15. PubMed ID: 1652024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.